Anzeige
Mehr »
Sonntag, 15.02.2026 - Börsentäglich über 12.000 News
FRIEDLANDS 10.000-JAHRE-SCHOCK: Der Kupfer-Engpass hat begonnen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3ERSY | ISIN: US5312297717 | Ticker-Symbol: LM0D
Tradegate
13.02.26 | 16:18
65,10 Euro
-1,36 % -0,90
Branche
Medien
Aktienmarkt
Sonstige
1-Jahres-Chart
LIBERTY MEDIA CORPORATION SERIES A LIBERTY FORMULA ONE Chart 1 Jahr
5-Tage-Chart
LIBERTY MEDIA CORPORATION SERIES A LIBERTY FORMULA ONE 5-Tage-Chart
RealtimeGeldBriefZeit
65,5566,4519:04
65,1066,8513.02.
ACCESS Newswire
549 Leser
Artikel bewerten:
(2)

Helen's Pink Sky Foundation to Feature on BWT Alpine Formula One Team's A525 to Raise Awareness of Batten Disease during the Formula 1 United States Grand Prix 2025

Since its launch in April, the foundation has dedicated nearly $1M for research and rallied a growing community

EDEN PRAIRIE, MN / ACCESS Newswire / October 16, 2025 / Helen's Pink Sky Foundation will take center stage at one of the world's premier sporting events this fall, with its logo set to appear on BWT Alpine Formula One Team's A525 for the Formula 1 United States Grand Prix in Austin, Texas, October 17-19. The high-profile placement will showcase the fight against Batten Disease to millions of racing fans worldwide, marking a major milestone in the foundation's mission to accelerate research and provide hope for affected families.

Helen's Pink Sky Foundation was founded in April 2025 by the Born and Schneider families after Helen was diagnosed with Late Infantile Batten Disease (CLN2). The rare genetic disorder affects only 2 to 4 children in every 100,000 births but devastates families with rapid neurodegeneration, seizures, vision loss, and premature death. The foundation is dedicated to funding groundbreaking research, raising awareness, and supporting families impacted by this devastating condition.

"No parent imagines having to fund medical research to save their child, but that's the reality with Batten Disease," said Stephanie Born, Helen's mom and co-founder of Helen's Pink Sky Foundation. "Every dollar we raise is about more than science - it's about buying time, creating hope, and fighting for more birthdays for Helen and all CLN2 kids. The momentum we've built in just a few months proves what's possible, but it also reminds us that we can't stop, because our children can't wait."

Since its launch earlier this year, the foundation has already invested nearly $1 million into world-class research efforts, supporting institutions such as Latus Bio, the Children's Hospital of Philadelphia, and the University of Minnesota. These collaborations are advancing promising gene therapy and neurological research, while the foundation continues to rally a growing donor community and raise international awareness to ensure no family faces Batten Disease alone.

"Every partnership, every donation, and every gesture of support matters," said Nick Schneider, Helen's uncle, a founding member of the Helen's Pink Sky Foundation, and President and CEO of Arctic Wolf, a Minnesota-based cybersecurity company, partner of BWT Alpine Formula One Team. "Since April, the progress we've made has shown what's possible when we work together - nearly a million dollars committed to cutting-edge research in just months. BWT Alpine Formula One Team is giving us a chance to show the world what momentum looks like, and I am grateful to them for helping us carry this fight onto this global racing stage."

"We are proud to support our partner and friends at Arctic Wolf this weekend to raise awareness for Helen's Pink Sky Foundation and the much-needed medical research to combat Batten Disease and to support those affected by it," said Guy Martin, Global Marketing Director, BWT Alpine Formula One Team.

The foundation has set a goal to secure an additional $1 million in funding over the next 12 months. Supporters can help make this possible by attending the inaugural Helen's Pink Sky Gala on October 25, 2025, or by contributing directly at Hope4Helen.org.

About Helen's Pink Sky Foundation

Helen's Pink Sky Foundation is committed to advocacy, research, and family support in the fight against Batten Disease (CLN2). Inspired by four-year-old Helen Born, the foundation funds groundbreaking studies, provides resources to affected families, and raises awareness for one of the most devastating pediatric genetic disorders. Learn more at https://www.hope4helen.org/.

Media Contact:
Ilina Cashiola
Ilina.cashiola@arcticwolf.com
202-340-0517

SOURCE: Helen's Pink Sky Foundation



View the original press release on ACCESS Newswire:
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/helens-pink-sky-foundation-to-feature-on-bwt-alpine-formula-one-teams-1087175

© 2025 ACCESS Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.